Our findings showed that patients treated with convalescent plasma had a trend that did not reach statistical significance towards faster resolution of their respiratory illness (as measured by tachypnoea or hypoxia), as well as improvement in multiple secondary endpoints (clinical status, hospital stay duration, intensive care unit requirement, and mechanical ventilation).
← all excerpts
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.
1
—
—